11 deals break $5B during first 3 weeks of January

As of Jan. 23, 11 deals worth more than $5 billion were inked globally, according to The Wall Street Journal, citing Dealogic.

Here are four things to know about the record-breaking period.

1. During the same period of 2017, seven $5 billion-plus deals were unveiled, according to Dealogic.

2. The cumulative value of the deals announced within the period is $207 billion. This is the highest amount since 2000 for the same period, according to the report.

3. Fast-paced dealmaking follows recent U.S. tax reform, which lowered the corporate tax rate from 35 percent to 21 percent.

Curt Moldenhauer, a partner at PricewaterhouseCoopers' deals practice, told The Wall Street Journal, "January is only the beginning of what we see as a very robust 2018. Certainly with tax reform being announced, a big piece of the puzzle was solved."

4. Some of the big deals include Sanofi's $11.6 billion bid to acquire all outstanding shares of U.S. hemophilia drugmaker Bioverativ and biopharmaceutical giant Celgene's $9 billion purchase of Juno Therapeutics.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars